Shares

Stock picks from our team of market veterans.

Premium

Is CSL a buy?

The outlook for CSL (one of the few true global leaders on the ASX) from the analysts (who aren’t always right) is that the recent price decline gives investors an improved access point to a high-quality global healthcare exposure. Let’s put CSL under the microscope.

James Dunn · April 14, 2025
Premium

Two ETFs with exposure to the market’s best global companies.

Because there’s no substitute for quality, investors who ‘buy this dip’ should stick to the highest-quality companies that can withstand whatever Trump throws at the global economy and geopolitical landscape. Here are two ETFs that provide exposure to the market’s best global companies.

Tony Featherstone · March 27, 2025

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.